Metanephric adenoma: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Infobox Disease | Name = Metanephric adenoma | Image = Metanephric adenoma - very high mag.jpg | Caption = Micrograph of a '''metanephric...")
 
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Infobox Disease |
__NOTOC__
  Name          = Metanephric adenoma |
{{Metanephric adenoma}}
  Image          = Metanephric adenoma - very high mag.jpg |
  Caption        = [[Micrograph]] of a '''metanephric adenoma''' with structures reminiscent of those seen in papillary [[renal cell carcinoma]]. [[H&E stain]].|
  DiseasesDB    = |
  ICD10          = {{ICD10|D|30|0|d|10}} |
  ICD9          = {{ICD9|223.0}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID        = |
}}


'''Metanephric adenoma''' (MA)is a rare, [[benign]] [[tumour]] of the [[kidney]], that can have a microscopic appearance similar to a [[nephroblastoma|nephroblastoma (Wilms tumours)]],<ref name=pmid18947770>{{cite journal |author=Bastos Netto JM, Esteves TC, Mattos RD, Tibiriçá SH, Costa SM, Vieira LJ |title=Metanephric adenoma: A rare differential diagnosis of renal tumor in children |journal=J Pediatr Urol |volume=3 |issue=4 |pages=340–341 |date=August 2007 |pmid=18947770 |doi=10.1016/j.jpurol.2006.10.003 |url=}}</ref> or a papillary [[renal cell carcinoma]].
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''.


It should not be confused with the pathologically unrelated, yet similar sounding, ''[[mesonephric adenoma]]''.
{{CMG}}; {{AE}} {{SC}}


==Symptoms==
{{SK}} Metanephroid renal tumor, nephrogenic nephroma
The symptoms may be similar to those classically associated with [[renal cell carcinoma]], and may include [[polycythemia]], [[abdominal pain]], [[hematuria]] and a palpable mass. Mean age at onset is around 40 years with a range of 5 to 83 years and the mean size of the tumour is 5.5&nbsp;cm with a range 0.3 to 15&nbsp;cm (1). Polycythemia is more frequent in MA than in any other type of renal tumour. Of further relevance is that this tumour is more commonly calcified than any other kidney neoplasm.<ref>Davis Cj jr, Barton JH, Sesterhenn IA, Mostofi FK (1995) Metanephric adenoma. Clinicopathologic study of fifty patients. Am J Surg Pathol 19(10):1101-1114.</ref> Surgery is curative and no other treatment is recommended. There is so far no evidence of metastases or local recurrence.


==Pathology==
==[[Metanephric adenoma overview|Overview]]==


===Histopathology===
==[[Metanephric adenoma historical perspective|Historical Perspective]]==
[[Image:metanephric adenoma high mag.jpg|thumb|right|[[Micrograph]] of a '''metanephric adenoma''' (right of image). Normal kidney is seen on the left. Kidney [[biopsy]]. [[PAS stain]].]]
[[Image:Metanephric adenoma high mag cropped.jpg|thumb|right|[[Micrograph]] of a '''metanephric adenoma''', right of image, showing the characteristic features (round nuclear membrane, no nucleoli, and fine chromatin).  Normal kidney is seen on the left of the image. Kidney [[biopsy]]. [[PAS stain]].]]
Metanephric adenoma is diagnosed histologically. The tumours can be located at upper pole, lower pole and mid-hilar region of the kidney; they are well circumscribed but unencapsulated, tan pink, with possible cystic and hemorrhagic foci. They show a uniform architecture of closely packed acinar or tubular structures of mature and bland appearance with scanty interposed stroma.<ref name=pmid9390023>{{Cite journal  | last1 = Kovacs | first1 = G. | last2 = Akhtar | first2 = M. | last3 = Beckwith | first3 = BJ. | last4 = Bugert | first4 = P. | last5 = Cooper | first5 = CS. | last6 = Delahunt | first6 = B. | last7 = Eble | first7 = JN. | last8 = Fleming | first8 = S. | last9 = Ljungberg | first9 = B. | last10 = Medeiros | first10 = L. Jeffrey | last11 = Moch | first11 = Holger | last12 = Reuter | first12 = Victor E. | last13 = Ritz | first13 = Eberhard | last14 = Roos | first14 = Göran | last15 = Schmidt | first15 = Dietmar | last16 = Srigley | first16 = John R. | last17 = Störkel | first17 = Stephan | last18 = Van Den Berg | first18 = Eva | last19 = Zbar | first19 = Bert | title = The Heidelberg classification of renal cell tumours | journal = J Pathol | volume = 183 | issue = 2 | pages = 131–3 |date=Oct 1997 | doi = 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G | pmid = 9390023 | display-authors = 8 }}</ref><ref name=pmid1333853>{{Cite journal  | last1 = Brisigotti | first1 = M. | last2 = Cozzutto | first2 = C. | last3 = Fabbretti | first3 = G. | last4 = Sergi | first4 = C. | last5 = Callea | first5 = F. | title = Metanephric adenoma | journal = Histol Histopathol | volume = 7 | issue = 4 | pages = 689–92 |date=Oct 1992 | doi =  | pmid = 1333853 }}</ref><ref name=pmid7755148>{{Cite journal | last1 = Jones | first1 = E. C. | last2 = Pins | first2 = M. | last3 = Dickersin | first3 = G. R. | last4 = Young | first4 = R. H. | title = Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases | journal = The American journal of surgical pathology | volume = 19 | issue = 6 | pages = 615–626 | year = 1995 | pmid = 7755148 | doi=10.1097/00000478-199506000-00001}}</ref><ref name=bostwick>Bostwick DG, Eble JN (2008) Urologic Surgical Pathology. St Louis, Mosby, p118.</ref><ref name=pmid9503505>{{Cite journal | last1 = Grignon | first1 = D. J. | last2 = Eble | first2 = J. N. | title = Papillary and metanephric adenomas of the kidney | journal = Seminars in diagnostic pathology | volume = 15 | issue = 1 | pages = 41–53 | year = 1998 | pmid = 9503505}}</ref> Cells are small with dark staining nuclei and inconspicuous nucleoli. Blastema is absent whereas calcospherites may be present. Glomeruloid figures are a striking finding, reminiscent of early fetal metenephric tissue. The lumen of the acini may contain otherwise epithelial infoldings or fibrillary material but it is quite often empty. Mitoses are conspicuously absent.<ref name=pmid9390023/><ref name=pmid1333853/><ref name=pmid7755148>{{Cite journal | last1 = Jones | first1 = E. C. | last2 = Pins | first2 = M. | last3 = Dickersin | first3 = G. R. | last4 = Young | first4 = R. H. | title = Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases | journal = The American journal of surgical pathology | volume = 19 | issue = 6 | pages = 615–626 | year = 1995 | pmid = 7755148 | doi=10.1097/00000478-199506000-00001}}</ref><ref name=bostwick/><ref name=pmid9503505>{{Cite journal | last1 = Grignon | first1 = D. J. | last2 = Eble | first2 = J. N. | title = Papillary and metanephric adenomas of the kidney | journal = Seminars in diagnostic pathology | volume = 15 | issue = 1 | pages = 41–53 | year = 1998 | pmid = 9503505}}</ref>
In the series reported by Jones ''et al.'' tumour cells were reactive for Leu7 in 3 cases of 5, to vimentine in 4 of 6, to cytocheratin in 2 of 6, to epithelial membrane antigen in 1 of 6 cases and muscle specific antigen in 1 of 6.<ref>Jones EC, Pins M, Dickersin GR, Young RH (1995) Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometry, cytogenetic and electron microscopic study of seven cases. Am J Surg Pathol 19(6):615-626.</ref>
Olgac ''et al.'' found that intense and diffuse immunoreactivity for alpha-methylacyl-CoA racemase (AMACR) is useful in differentiating renal cell carcinoma from MA but a panel including AMACR, CK7 and CD57 is better in this differential diagnosis.<ref>Olgac S, Hutchinson B, Tickoo  SK, Reuter VE (2006) Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol 19:218-224.</ref>
Differential diagnosis may be quite difficult indeed as exemplified by the three malignancies initially diagnosed as MA that later metastasized, in the report by Pins et al.<ref>Pins MR, Jones EC, Martul EV, Kamat BR, Umlas J, Renshaw AA (1999) Metanephric adenoma-like tumours of the kidney. Report of three malignancies with emphasis on discriminating features. Arch Pathol Lab Med. 123:415-420.</ref>


===Cytogenetic characteristics===
==[[Metanephric adenoma classification|Classification]]==


Brunelli ''et al.'' stated  that genetic analysis of chromosome 7, 17, and Y may facilitate discrimination of MA from papillary renal cell carcinoma in difficult cases. Their study showed that MA lacks the frequent gain of chromosomes 7 and 17 and losses of the Y chromosome that are typical of papillary renal cell neoplasms, suggesting that MA is not related to renal cell carcinoma and papillary adenoma.<ref>Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L (2003) Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol 16(10):1060-1063.</ref>
==[[Metanephric adenoma pathophysiology|Pathophysiology]]==


==Treatment==
==[[Metanephric adenoma causes|Causes]]==
As metanephric adenomas are considered benign, they can be left in place, i.e. no treatment is needed.<ref name=pmid18185471>{{cite journal |author=Galmiche L, Vasiliu V, Poirée S, Hélénon O, Casanova JM, Brousse N |title=[Diagnosis of renal metanephric adenoma: relevance of immunohistochemistry and biopsy] |language=French |journal=Ann Pathol |volume=27 |issue=5 |pages=365–8 |date=October 2007 |pmid=18185471 |doi= |url=}}</ref>
 
==[[Metanephric adenoma differential diagnosis|Differentiating Metanephric adenoma]]==
 
==[[Metanephric adenoma epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Metanephric adenoma risk factors|Risk Factors]]==
 
==[[Metanephric adenoma screening|Screening]]==
 
==[[Metanephric adenoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==History==
==Diagnosis==
MA has been described in the past under other names such as néphrome néphronogène, metanephroider Nierentumor and nephroblastomartiges Nierenadenom (5) but the term metanephric adenoma was suggested by Brisigotti, Cozzutto et al. in 1992 and then widely accepted.
[[Metanephric adenoma staging|Staging]] | [[Metanephric adenoma history and symptoms|History and Symptoms]] | [[Metanephric adenoma physical examination|Physical Examination]] | [[Metanephric adenoma laboratory findings|Laboratory Findings]]  | [[Metanephric adenoma x ray|X Ray]] | [[Metanephric adenoma CT|CT]] | [[Metanephric adenoma MRI|MRI]] [[Metanephric adenoma ultrasound|Ultrasound]] | [[Metanephric adenoma other imaging findings|Other Imaging Findings]] | [[Metanephric adenoma other diagnostic studies|Other Diagnostic Studies]] | [[Metanephric adenoma biopsy|Biopsy]]
Prior to this report, Nagashima et al. in 1991 had not offered a nosological innovation for their two cases<ref>Nagashima Y, Arai N, Tanaka Y, Yoshida S, Sumino K, Ohaki Y, Matsushita K, Morita T, Misugi K 81991) Case record: two cases of renal epithelial tumour resembling immature nephron. Virchow Arch A Pathol Anat 418:77-81.</ref> whereas the denomination of néphrome néphronogène proposed by Pages and Granier in 1980 had gone largely undetected.<ref>Pages A, Granier M (1980) Le néphrome néphronogène. Arch Anat Cytol Pathol 28:99-103.</ref>


==References==
==Treatment==
{{reflist|2}}
[[Metanephric adenoma medical therapy|Medical therapy]] | [[Metanephric adenoma surgery|Surgery]] | [[Metanephric adenoma primary prevention|Primary prevention]]  | [[Metanephric adenoma secondary prevention|Secondary prevention]] | [[Metanephric adenoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Metanephric adenoma future or investigational therapies|Future or Investigational Therapies]]


==External links==
==Case Studies==
*[http://arpa.allenpress.com/arpaonline/?doi=10.1043%2F0003-9985(1999)123%3C0415:MALTOT%3E2.0.CO%3B2&request=get-document Metanephric adenoma mimics] - allenpress.com.
[[Metanephric adenoma case study one|Case #1]]
*[http://webpathology.com/case.asp?case=65 Metanephric adenoma - micrographs] - webpathology.com.


{{Urologic neoplasia}}
{{Urologic neoplasia}}


[[Category:Benign renal neoplasms]]
{{WH}}
{{WS}}
 
[[Category:Disease]]
[[Category:Types of cancer]]

Latest revision as of 14:00, 9 November 2015

Metanephric adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metanephric adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Metanephric adenoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Metanephric adenoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Metanephric adenoma

CDC on Metanephric adenoma

Metanephric adenoma in the news

Blogs on Metanephric adenoma

Directions to Hospitals Treating Metanephric adenoma

Risk calculators and risk factors for Metanephric adenoma

For patient information click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Synonyms and keywords: Metanephroid renal tumor, nephrogenic nephroma

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metanephric adenoma

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy

Treatment

Medical therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Urologic neoplasia

Template:WH Template:WS